04/30/2026
We are pleased to introduce Dr. Elizabeth Volkmann as a speaker at the 2026 national scleroderma conference in Ottawa.
Dr. Elizabeth Volkmann is an Associate Professor in the Division of Rheumatology at University of California, Los Angeles, where she serves as the Director of the UCLA Scleroderma Program and the founder and Co-Director of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program. Her research focuses on the discovery of novel biomarkers that predict response to ILD-targeted therapies. She also has an enduring interest in exploring how the gut microbiome contributes to the pathogenesis of ILD and systemic sclerosis. Dr. Volkmann practices Holistic medicine, an approach that addresses the whole person, including psychological, spiritual, ethical, familial and societal, as well as the biological dimensions of disease. Central to her healing philosophy is the recognition of the uniqueness of each patient and the fostering of equality in the doctor-patient partnership. She is also the proud founder of Women in Scleroderma (WINS), a nonprofit organization dedicated to advancing the careers of women scientists and clinicians working in this field.